» Articles » PMID: 24572046

Correlation of EGFR, PEGFR and P16INK4 Expressions and High Risk HPV Infection in HIV/AIDS-related Squamous Cell Carcinoma of Conjunctiva

Overview
Publisher Biomed Central
Date 2014 Feb 28
PMID 24572046
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Squamous cell carcinoma of conjunctiva has increased tenfold in the era of HIV/AIDS. The disease pattern has also changed in Africa, affecting young persons, with peak age-specific incidence of 30-39 years, similar to that of Kaposi sarcoma, a well known HIV/AIDS defining neoplasm. In addition, the disease has assumed more aggressive clinical course. The contributing role of exposure to high risk HPV in the development of SCCC is still emerging.

Objective: The present study aimed to investigate if immunohistochemical expressions of EGFR, pEGFR and p16, could predict infection with high risk HPV in HIV-related SCCC.

Methods: FFPE tissue blocks of fifty-eight cases diagnosed on hematoxylin and eosin with SCCC between 2005-2011, and subsequently confirmed from medical records to be HIV positive at the department of human pathology, UoN/KNH, were used for the study. Immunohistochemistry was performed to assess the expressions of p16INK4A, EGFR and pEGFR. This was followed with semi-nested PCR based detection and sequencing of HPV genotypes. The sequences were compared with the GenBank database, and data analyzed for significant statistical correlations using SPSS 16.0. Ethical approval to conduct the study was obtained from KNH-ERC.

Results: Out of the fifty-eight cases of SCCC analyzed, twenty-nine (50%) had well differentiated (grade 1), twenty one (36.2%) moderately differentiated (grade 2) while eight (13.8%) had poorly differentiated (grade 3) tumours. Immunohistochemistry assay was done in all the fifty eight studied cases, of which thirty nine cases (67.2%) were positive for p16INK4A staining, forty eight cases (82.8%) for EGFR and fifty one cases (87.9%) showed positivity for p-EGFR. HPV DNA was detected in 4 out of 40 SCCC cases (10%) in which PCR was performed, with HPV16 being the only HPV sub-type detected. Significant statistical association was found between HPV detection and p16INK4 (p=0.000, at 99% C.I) and EGFR (p=0.028, at 95% C.I) expressions, but not pEGFR. In addition, the expressions of these biomarkers did not show any significant association with tumor grades.

Conclusion: This study points to an association of high risk HPV with over expressions of p16INK4A and EGFR proteins in AIDS-associated SCCC.

Citing Articles

The Use of Panitumumab-IRDye800CW in a Novel Murine Model for Conjunctival Squamous Cell Carcinoma.

Youn G, Case A, Jarin T, Li B, Swarup A, Naranjo A Transl Vis Sci Technol. 2022; 11(7):23.

PMID: 35895055 PMC: 9344218. DOI: 10.1167/tvst.11.7.23.


Expression, intracellular localization, and mutation of EGFR in conjunctival squamous cell carcinoma and the association with prognosis and treatment.

Sakai A, Tagami M, Kakehashi A, Katsuyama-Yoshikawa A, Misawa N, Wanibuchi H PLoS One. 2020; 15(8):e0238120.

PMID: 32833992 PMC: 7444806. DOI: 10.1371/journal.pone.0238120.


Clinical characteristics, HIV status, and molecular biomarkers in squamous cell carcinoma of the conjunctiva in Ghana.

Merz L, Afriyie O, Jiagge E, Adjei E, Foltin S, Ludwig M Health Sci Rep. 2019; 2(2):e108.

PMID: 30809594 PMC: 6375545. DOI: 10.1002/hsr2.108.


Human papilloma virus identification in ocular surface squamous neoplasia by p16 immunohistochemistry and DNA chip test: A strobe-compliant article.

Shrestha T, Choi W, Kim G, Yang J, Yoon K Medicine (Baltimore). 2019; 98(2):e13944.

PMID: 30633172 PMC: 6336645. DOI: 10.1097/MD.0000000000013944.


p16INK4A expression is frequently increased in periorbital and ocular squamous lesions.

Kobalka P, Abboud J, Liao X, Jones K, Lee B, Korn B Diagn Pathol. 2015; 10:175.

PMID: 26400483 PMC: 4581440. DOI: 10.1186/s13000-015-0396-8.


References
1.
Parkin D, Wabinga H, Nambooze S, Wabwire-Mangen F . AIDS-related cancers in Africa: maturation of the epidemic in Uganda. AIDS. 2000; 13(18):2563-70. DOI: 10.1097/00002030-199912240-00010. View

2.
Weinberger P, Yu Z, Haffty B, Kowalski D, Harigopal M, Brandsma J . Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. J Clin Oncol. 2006; 24(5):736-47. DOI: 10.1200/JCO.2004.00.3335. View

3.
Thomas J, Primeaux T . Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma?. Ann Diagn Pathol. 2011; 16(2):91-9. DOI: 10.1016/j.anndiagpath.2011.09.002. View

4.
Shillitoe E . Papillomaviruses as targets for cancer gene therapy. Cancer Gene Ther. 2005; 13(5):445-50. DOI: 10.1038/sj.cgt.7700926. View

5.
Dray M, Russell P, Dalrymple C, Wallman N, Angus G, Leong A . p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies. Pathology. 2005; 37(2):112-24. DOI: 10.1080/00313020500058607. View